Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
EBERHARD KARLS UNIVERSITÄT TÜBINGEN is currently managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners, indicating that each application is being reviewed by a different official. The prosecution is also distributed across 2 distinct art units, which suggests a variety of technical focuses within the biotechnology sector. MIKNIS, ZACHARY J is the busiest examiner for this portfolio, currently overseeing 1 busiest examiner pending action.
The presence of 2 pending office actions across 2 distinct examiners and 2 distinct art units indicates a decentralized prosecution environment. Since MIKNIS, ZACHARY J is responsible for 1 busiest examiner pending action, the workload is divided among the assigned staff. This arrangement requires the university to manage 2 distinct examiners, each operating within a different art unit. For practitioners, this means that the strategy for the Biotechnology & Pharmaceuticals filings must be tailored to the specific requirements of the different art units and their respective examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIKNIS, ZACHARY J | 1 | 68.6% | +32.2% |
| SEGED, NEBYATE SAMUEL | 1 | 31.3% | +49.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18155648 | SYSTEM FOR PROTECTION AGAINST AIRBORNE PATHOGENS IN A SURGICAL ENVIRONMENT | SEGED, NEBYATE SAMUEL | 67d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18155648 | SYSTEM FOR PROTECTION AGAINST AIRBORNE PATHOGENS IN A SURGICAL ENVIRONMENT | SEGED, NEBYATE SAMUEL | 67d overdue |
| 18455196 | Wound Healing Promoting Protein | MIKNIS, ZACHARY J | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18455196 | Wound Healing Promoting Protein | MIKNIS, ZACHARY J | 1658 | §112 | Final Rejection | — | Pending | Aug 24, 2023 |
| 18155648 | SYSTEM FOR PROTECTION AGAINST AIRBORNE PATHOGENS IN A SURGICAL ENVIRONMENT | SEGED, NEBYATE SAMUEL | 1758 | §102§103 | Non-Final OA | 67d overdue | Pending | Jan 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial